drugset
drugset / Trial / NCT04257617

A Trial of ZL-1201 in Subjects With Advanced Cancer

NCT04257617 ↗

Phase 1 Completed 37 enrolled Zai Lab (Shanghai) Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

First in Human, Phase I Trial of ZL-1201 in Subjects with Advanced Cancer

Timeline

Start
2020-05-11
Primary completion
2022-05-17
Completion
2023-01-19

Drugs

EvaluationDrugModalityDoseRoute
Subject ZL-1201 Unknown — —

Indications

No indication recorded.